Facebook
TwitterThe Department of Health and Social Care (DHSC) COVID-19 self-test lateral flow device (LFD) was lawfully introduced to the UK market when the DHSC, as legal manufacturer of the product, obtained an Exceptional Use Authorisation in December 2020 from the Medicines and Healthcare products Regulatory Agency (MHRA).
This is the correct regulatory process in the UK for products that have not yet been assessed by a UK-approved body.
The Incident and Corrective and Preventative Action Report details the formal review that NHS Test and Trace undertook at the request of the MHRA in June 2021 when the US Food and Drug Administration (FDA) released a safety notice in the US for the Innova LFD Antigen Test. The review summarises the reasons why DHSC continued to use the product in the UK.
Facebook
TwitterAs announced on 7 June 2022, this will be the final publication of the Weekly Statistics for NHS Test and Trace (England). In line with the Government’s ‘Living with COVID-19’ strategy, most free testing in England ended on 1 April 2022. The subsequent reduction in testing numbers and across use cases has resulted in a reduction in the breadth of the statistics publication. Information relating to testing is available on the Coronavirus (COVID-19) dashboard.
The data reflects the NHS Test and Trace operation in England since its launch on 28 May 2020.
This includes 2 weekly reports:
1. NHS Test and Trace statistics:
2. Rapid asymptomatic testing statistics: number of lateral flow device (LFD) tests reported by test result.
There are 3 sets of data tables accompanying the reports.
Facebook
Twitter <p class="gem-c-attachment_metadata"><span class="gem-c-attachment_attribute"><abbr title="OpenDocument Spreadsheet" class="gem-c-attachment_abbr">ODS</abbr></span>, <span class="gem-c-attachment_attribute">14.2 KB</span></p>
<p class="gem-c-attachment_metadata">
This file is in an <a href="https://www.gov.uk/guidance/using-open-document-formats-odf-in-your-organisation" target="_self" class="govuk-link">OpenDocument</a> format
This file may not be suitable for users of assistive technology.
Request an accessible format. If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email <a href="mailto:publications@phe.gov.uk" target="_blank" class="govuk-link">publications@phe.gov.uk</a>. Please tell us what format you need. It will help us if you say what assistive technology you use.
<p class="gem-c-attachment_metadata"><span class="gem-c-attachment_attribute"><abbr title="OpenDocument Spreadsheet" class="gem-c-attachment_abbr">ODS</abbr></span>, <span class="gem-c-attachment_attribute">12.5 KB</span></p>
<p class="gem-c-attachment_metadata">
This file is in an <a href="https://www.gov.uk/guidance/using-open-document-formats-odf-in-your-organisation" target="_self" class="govuk-link">OpenDocument</a> format
This file may not be suitable for users of assistive technology.
<details data-module="ga4-event-tracker" data-ga4-event='{"event_name":"select_content","type":"detail","text":"Request an accessible format.","section":"Request an access
Facebook
TwitterThis information relates to suppliers that were successfully awarded government contracts after going through the testing triage process and shows who initially identified them, where they were flagged to and who referred them to the COVID-19 response.
Facebook
TwitterThe data reflects the first 25 weeks of operation of NHS Test and Trace in England, and testing operations in the UK since late March.
Facebook
TwitterSets out the number of people tested weekly in England between 30 January and 27 May, before the launch of the NHS test and trace service.
The data is not directly comparable with data in the NHS test and trace time series due to difference in the dates on which the data was extracted.
Facebook
TwitterThe attachment lists 30 periodic summary reports (PSRs) which were submitted to the Medicines and Healthcare products Regulatory Agency (MHRA) as a post market surveillance condition of the exceptional use authorisation DEU/012/2020/003.
Facebook
TwitterThis fortnightly official statistic provides information on the number of defence personnel who have attended a COVID-19 test through the UK National Testing Programme; and for the UK Armed Forces, the number of positive cases of COVID-19.
Facebook
TwitterOfficial statistics are produced impartially and free from political influence.
Facebook
TwitterOfficial statistics are produced impartially and free from political influence.
Facebook
TwitterThe data reflects the NHS Test and Trace operation in England since its launch on 28 May 2020.
This includes 2 weekly reports:
1. NHS Test and Trace statistics:
2. Rapid asymptomatic testing statistics: number of lateral flow device (LFD) tests reported by test result.
There are 4 sets of data tables accompanying the reports.
For transparency, we’ve added LFD dispatches data outside of the original reported timeframe, up to and including June 2023.
Facebook
TwitterOn 21 February 2022 the Prime Minister set out a new plan for ‘Living with COVID-19’ with the end of free universal testing for the general public on 1 April 2022. As a result the frequency of this publication and accompanying data tables will reduce from weekly publications to 2-weekly publications of weekly data from 14 April 2022 (period covering 31 March 2022 to 6 April 2022). Furthermore, it is anticipated that the changes in testing policy will result in a noticeably smaller publication, with a reduction in data output tables. Details of affected data output tables will be communicated on 31 March 2022.
The data reflects the NHS Test and Trace operation in England since its launch on 28 May 2020.
This includes 2 weekly reports:
1. NHS Test and Trace statistics:
2. Rapid asymptomatic testing statistics: number of lateral flow device (LFD) tests reported by test result.
There are 4 sets of data tables accompanying the reports.
Facebook
TwitterNote: Routine contact tracing in England ended on 24 February 2022 in line with the government’s plan for living with COVID-19. Therefore, the regional contact tracing data has not been updated beyond week ending 23 February 2022.
The data reflects the NHS Test and Trace operation in England since its launch on 28 May 2020.
This includes 2 weekly reports:
1. NHS Test and Trace statistics:
2. Rapid asymptomatic testing statistics: number of lateral flow device (LFD) tests reported by test result.
There are 4 sets of data tables accompanying the reports.
Facebook
TwitterThis statistical note contains figures relating to tests and people who were tested under pillar 1 or pillar 2 of the government testing strategy.
Pillar 1 is swab testing in Public Health England (PHE) labs and NHS hospitals for those with a clinical need, and health and care workers.
Pillar 2 is swab testing for the wider population, through commercial partnerships.
Facebook
TwitterUploaded new ‘Tests conducted: 28 May 2020 to 24 February 2021’ due to an error in the previous version (see the information tab of the spreadsheet for further details).
The data reflects the NHS Test and Trace operation in England since its launch on 28 May 2020.
This includes 2 weekly reports:
1. NHS Test and Trace statistics:
2. Rapid asymptomatic testing statistics:
There are 4 sets of data tables accompanying the reports.
Facebook
TwitterThe publication of statistics for NHS Test and Trace (England) will end on 23 June 2022. Following policy changes to testing in the government’s plan for ‘Living with COVID-19’, including the end of free universal testing for the public on 1 April 2022, there has been an overall decline across all statistics within these publications. These publications will therefore be discontinued. Data will be published as usual on 9 June 2022 and 23 June 2022.
For information on testing, case rate, hospitalisation and deaths, refer to the https://coronavirus.data.gov.uk/">Coronavirus (COVID-19) dashboard.
The data reflects the NHS Test and Trace operation in England since its launch on 28 May 2020.
This includes 2 weekly reports:
1. NHS Test and Trace statistics:
2. Rapid asymptomatic testing statistics: number of lateral flow device (LFD) tests reported by test result.
There are 4 sets of data tables accompanying the reports.
Facebook
TwitterThe data includes:
case rate per 100,000 population
case rate per 100,000 population aged 60 years and over
percentage change in case rate per 100,000 from previous week
percentage of individuals tested positive
number of individuals tested per 100,000
number of deaths within 28 days of positive COVID-19 test
NHS pressures by Sustainability and Transformation Partnership (STP)
See the detailed data on https://www.england.nhs.uk/statistics/statistical-work-areas/covid-19-hospital-activity/">hospital activity.
See the https://coronavirus.data.gov.uk/?_ga=2.108721154.1297948817.1612958412-1961839927.1610968060">detailed data on the progress of the coronavirus pandemic. This includes the number of people testing positive, case rates and deaths within 28 days of positive test by upper tier local authority.
See the latest lower-tier local authority watchlist. This includes epidemiological charts containing case numbers, case rates, persons tested and positivity at lower-tier local authority level.
Facebook
TwitterThis data contains the number of pillar 2 (swab) tests that were processed daily between 28 May and 16 September 2020 by lower tier local authorities.
This data will not align with figures published on the https://coronavirus.data.gov.uk/">coronavirus testing in the UK dashboard as they are derived from a different data source with different associated methodology. See the note above for more information.
Facebook
TwitterOn 21 February, in a statement to the House of Commons on Living with COVID-19, the Prime Minister stated that the NHS Test and Trace Programme: “…cost a further £15.7 billion in this financial year, and £2 billion in January alone at the height of the Omicron wave.” This ad hoc publication presents the source of these figures and how they should be interpreted.
Facebook
TwitterInformation on this page outlines payments made to institutions for claims they have made to ESFA for various grants. These include, but are not exclusively, coronavirus (COVID-19) support grants. Information on funding for grants based on allocations will be on the specific GOV.UK page for the grant.
Financial assistance available to schools to cover increased premises, free school meals and additional cleaning-related costs associated with keeping schools open over the Easter and summer holidays in 2020, during the coronavirus (COVID-19) pandemic.
Financial assistance available to meet the additional cost of the provision of free school meals to pupils and students where they were at home during term time, for the period January 2021 to March 2021.
Financial assistance for additional transition support provided to year 11 pupils by alternative provision settings from June 2020 until the end of the autumn term (December 2020).
Financial assistance for schools, colleges and other exam centres to run exams and assessments during the period October 2020 to March 2021 (or for functional skills qualifications, October 2020 to December 2020).
Financial assistance for mentors’ salary costs on the academic mentors programme from the start of their training until 31 July 2021, with adjustment for any withdrawals.
Financial assistance for schools and colleges to support them with costs they have incurred when conducting asymptomatic testing site (ATS) onsite testing, in line with departmental testing policy.
Details of payments included in the data cover the following periods:
| Phase | Period |
|---|---|
| Phase 1 | 4 January 2021 to 5 March 2021 |
| Phases 2 and 3 | 6 March 2021 to 1 April 2021 |
| Phase 4 | 2 April 2021 to 23 July 2021 |
Also included are details of exceptional costs claims made by schools and colleges that had to hire additional premises or make significant alterations to their existing premises to conduct testing from 4 January 2021 to 19 March 2021.
<h3 id="coronavirus-covid-19-workforce-fund-for-schoolshttpswwwgovukgovernmentpublicationscoronavirus-covid-19-workforce-fund-for-schoolscoronavirus-covid-19-workforce-fund-to-support-schools-with-costs-of-staff-absences-from-22-november-to-31-december-2021-and-coronavirus-covid-19-
Facebook
TwitterThe Department of Health and Social Care (DHSC) COVID-19 self-test lateral flow device (LFD) was lawfully introduced to the UK market when the DHSC, as legal manufacturer of the product, obtained an Exceptional Use Authorisation in December 2020 from the Medicines and Healthcare products Regulatory Agency (MHRA).
This is the correct regulatory process in the UK for products that have not yet been assessed by a UK-approved body.
The Incident and Corrective and Preventative Action Report details the formal review that NHS Test and Trace undertook at the request of the MHRA in June 2021 when the US Food and Drug Administration (FDA) released a safety notice in the US for the Innova LFD Antigen Test. The review summarises the reasons why DHSC continued to use the product in the UK.